TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data ...

An international research team, with significant involvement from the Medical University of Vienna, has developed a new AI-based analysis method that can accurately classify brain tumors using genetic ...

With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on ...

Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, ...

People with aphantasia have no mental imagery—and they’re offering brain scientists a window into consciousness ...

Illumina introduces TruPath Genome, setting a new standard in genomic insight: San Diego Thursday, February 26, 2026, 16:00 Hrs [IST] Illumina, Inc. announced the launch of TruPat ...

The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...

A new review titled Artificial Intelligence and the Discovery of Antibiotics: Reinventing with Opportunities, Challenges, and ...

Anemia in young adult women is rarely caused by a single factor. Instead, it reflects a layered interaction of nutritional deficiencies, physiological demands, chronic illnesses, genetic ...

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...

Stephen Whitelam, a researcher whose work spans thermodynamic theory and machine learning, has described a framework for ...